ROSEN Law Firm Encourages REGENXBIO Investors to Seek Legal Counsel

Investors advised to protect their rights after potential securities law violations.

Apr. 6, 2026 at 10:10am

Got story updates? Submit your updates here. ›

The ROSEN Law Firm, a global investor rights law practice, is urging investors in REGENXBIO, Inc. to seek legal representation following potential securities law violations by the company. The firm is investigating claims on behalf of REGENXBIO investors and encouraging them to contact the firm to discuss their options.

Why it matters

REGENXBIO is a leading biotechnology company focused on gene therapy treatments. Any potential securities law violations could have significant implications for the company's future and impact investors who have put their money into the firm.

The details

The ROSEN Law Firm is investigating potential securities claims on behalf of REGENXBIO investors. The firm is looking into whether the company and its executives made materially false and/or misleading statements, or failed to disclose material adverse facts about REGENXBIO's business, operations, and prospects.

  • The investigation was launched on April 5, 2026.

The players

ROSEN Law Firm

A global investor rights law practice that specializes in representing investors in securities fraud class actions and shareholder derivative litigation.

REGENXBIO, Inc.

A leading biotechnology company focused on developing gene therapy treatments for various diseases.

Got photos? Submit your photos here. ›

What they’re saying

“We encourage all REGENXBIO investors to contact the firm to discuss their legal rights and options.”

— Laurence Rosen, Managing Partner, ROSEN Law Firm

What’s next

The ROSEN Law Firm is urging REGENXBIO investors to contact the firm to discuss their options. The firm will continue its investigation into the potential securities law violations.

The takeaway

This case highlights the importance for investors to be vigilant and seek legal counsel when there are potential issues with a company they have invested in. The ROSEN Law Firm's investigation could lead to significant consequences for REGENXBIO and provide recourse for affected investors.